@article {Patel2020.01.08.898494, author = {Manthan Patel and Divyesh Patel and Subhamoy Datta and Umashankar Singh}, title = {HDAC inhibitor Givinostat targets DNA-binding of human CGGBP1}, elocation-id = {2020.01.08.898494}, year = {2020}, doi = {10.1101/2020.01.08.898494}, publisher = {Cold Spring Harbor Laboratory}, abstract = {The antineoplastic agent Givinostat inhibits histone deacetylases. We present here our finding that the DNA-binding of human CGGBP1 is also inhibited by Givinostat. CGGBP1, a DNA-binding protein, is required for cancer cell proliferation. In our quest to exploit the potential anti-proliferative effects of CGGBP1 inhibition, we have developed a simple screening assay to identify chemical inhibitors of DNA-protein interactions. We have applied this screen for human CGGBP1 on a library of 1685 compounds and found that Givinostat is a direct inhibitor of CGGBP1-DNA interaction. The mechanism of action of Givinostat should thus extend beyond HDACs to include the inhibition of the myriad functions of CGGBP1 that depend on its binding to the DNA.DBIDrCGGBP1}, URL = {https://www.biorxiv.org/content/early/2020/01/08/2020.01.08.898494}, eprint = {https://www.biorxiv.org/content/early/2020/01/08/2020.01.08.898494.full.pdf}, journal = {bioRxiv} }